QUEBEC, June 11 /CNW Telbec/ - Victhom Human Bionics Inc. ("Victhom") (TSX-V: VHB) today reported the results of its Annual General Meeting of shareholders held in Montreal, Quebec on June 10, 2010.
The shareholders approved the motions put forth at the meeting to re-appoint the four directors of the Company: Daniel Johnson, Nitin Kaushal, Martin Leblanc and Normand Rivard and to appoint Ernst & Young LLP as the Company's auditors.
At their meeting held directly following the Annual General Meeting, the directors re-appointed Mr. Daniel Johnson as Chairman of the Board.
Victhom discovers, develops and manufactures bionic devices involved in the treatment of a variety of physical and physiological dysfunctions. Victhom Biotronix business developed the Power Knee, the world's first and only motor-powered, artificially intelligent prosthesis for above-knee amputees. The Power Knee is commercialized by Ossur, a global leader in the orthotics and prosthetics ("O&P") market. Victhom also has a 44.4% interest in Neurostream Technologies, General Partnership, a joint venture with Otto Bock HealthCare, which objective is to bring to market the Neurostep(R) System, and to develop neuromodulation products in other indications such as sleep apnea.
Some of the statements made herein may constitute forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause Victhom's actual results, performance or achievements to be materially different from those expressed or implied by any of Victhom's statements. Actual events or results may differ materially. We disclaim any intention, and assume no obligation, to update these forward-looking statements.
SOURCE Victhom Human Bionics Inc.
For further information: For further information: Normand Rivard, President & CEO, Victhom Human Bionics Inc., Tel.: 418-872-5665, Fax: 418-864-7034, email@example.com; www.victhom.com; Source: Victhom Human Bionics Inc.